Evaluating the efficacy of Phenocain Plus drops in patients undergoing cataract surgery

Not Applicable

• Conditions: Health Condition 1: H259- Unspecified age-related cataract

• Registration Number: CTRI/2020/12/030145
• Lead Sponsor: Entod Pharmaceuticals Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients having cataract and willing to sign informed consent.

Patients between the age 18 to 75 years.

Patients must be able to communicate effectively with study personnel.

Patients having grade 2 to 3 Cataracts shall be included.

Patients scheduled to or taking surgery for cataract.

Exclusion Criteria

Ophthalmological criteria:

1) Corrected visual acuity < 0.5

2) Refractive Error with a spherical equivalent > +6 or smaller - 6 D

3) Elevated intraocular pressure (higher than 22 mmHg)

4) Relevant anisocoria or pupil deformation

5) History of eye surgery apart from laser trabeculoplasty less than three months

previously or extraocular surgery such as strabismus surgery

6) Topical ocular medication influencing IOP (intraocular pressure) or pupil size within 3

months prior to study-start

7) Combined surgery Non-surgical conditions in the eye to be operated

8) Iatrogenic or traumatic or congenital cataract

9) Pupillary abnormalities (irregular)

10) Very dark iris - Iris synechiae

11) Eye movement disorder (Nystagmus)

12) Dacryocystitis and all others pathologies of tears drainage system

13) History of Inflammatory ocular disease (Iritis, uveitis, herpetic keratitis)

14) Corneal, epithelial, stromal or endothelial, residual or evolutionary disease

(including corneal ulceration and superficial punctuate keratitis

15)s - Pseudoexfoliation, exfoliative syndrome

Study & Design

• Study Type: Interventional
• Study Design: Not specified